Brief: Curasight Appoints CRO To Run Phase 2 Study With uTrace In Prostate Cancer

Curasight A/S

13/12/2023 16:56

Dec 13 (Reuters) - Curasight A/S  CURAS.TE :
    * CURASIGHT A/S APPOINTS CRO TO RUN PHASE 2 STUDY WITH
UTRACE IN
PROSTATE CANCER

Source text for Eikon:  ID:nWkrx8WXv 
Further company coverage:  CURAS.TE 

 ((Reuters.Briefs@thomsonreuters.com;))